Login / Signup

Efficacy and safety of BNT162b2 mRNA vaccine in a cohort of 90 transfusion dependent thalassemia patients.

M MarzialiP PuglieseA A LosardoM RibersaniE AnastasiA AngeloniA PavanGiuseppe Gentile
Published in: Transfusion medicine (Oxford, England) (2024)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • sickle cell disease